Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 371

Results For "ED"

11241 News Found

Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today
Policy | May 07, 2026

Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today

These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring


Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
News | May 07, 2026

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity


CARE Hospitals performs rare organ-preserving pancreatic surgery
Hospitals | May 07, 2026

CARE Hospitals performs rare organ-preserving pancreatic surgery

Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


Neurobion introduces nerve pain relief cream
Healthcare | May 07, 2026

Neurobion introduces nerve pain relief cream

The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil


Merck completes $5.8 billion acquisition of Terns Pharma
News | May 07, 2026

Merck completes $5.8 billion acquisition of Terns Pharma

At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
Policy | May 07, 2026

Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness

The 40-second film brings children to the forefront of the narrative